https://healthheraldgrenada.com/article/906308726-global-widget-celebrates-10-years-as-a-leader-in-premium-gummy-manufacturing Health Herald Grenada en PressRelease 2026-04-17T13:00:00+00:00 Global Widget Celebrates 10 Years as a Leader in Premium Gummy Manufacturing https://ml.globenewswire.com/media/56ac8ec6-8f17-4b3a-9f26-ae171e860afb/small/icn685386-icnglobal-widget-logo-jpg.jpg https://healthheraldgrenada.com/article/906310010-omada-health-helps-members-on-glp-1s-lose-more-fat-preserve-muscle-mass-and-improve-mental-health-new-study-finds Health Herald Grenada en PressRelease 2026-04-17T13:00:00+00:00 Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://healthheraldgrenada.com/article/906304382-alps-group-appoints-former-ernst-young-partner-to-board-of-directors-strengthening-governance-and-capital-markets-oversight Health Herald Grenada en PressRelease 2026-04-17T12:30:00+00:00 Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight https://ml.globenewswire.com/media/ce232220-dc3f-4308-a2b7-f695be7b9f0b/small/alps-global-holding-berhad-logo-01-png.png https://healthheraldgrenada.com/article/906308789-wilcrest-pharma-awarded-outsourced-compounded-preparations-agreement-with-premier-inc Health Herald Grenada en PressRelease 2026-04-17T12:30:00+00:00 Wilcrest Pharma Awarded Outsourced Compounded Preparations Agreement with Premier, Inc. https://ml.globenewswire.com/media/ZDdjZmViMGQtOGMyZC00OWJmLWJiMjItNTY0ZTBiY2M4YTEyLTUwMDE2MTA5Ni0yMDI2LTA0LTE3LWVu/tiny/Wilcrest-Pharma.png https://healthheraldgrenada.com/article/906309029-intelligent-bio-solutions-advances-upcoming-fda-510-k-submission-successfully-completes-penetration-testing-with-no-major-vulnerabilities-identified Health Herald Grenada en PressRelease 2026-04-17T12:30:00+00:00 Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://healthheraldgrenada.com/article/906310094-vaxart-announces-share-purchase-agreement-for-up-to-25-million-with-lincoln-park-capital Health Herald Grenada en PressRelease 2026-04-17T12:30:00+00:00 Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://healthheraldgrenada.com/article/906308984-first-steps-developmental-services-expands-services-in-woburn Health Herald Grenada en PressRelease 2026-04-17T12:05:00+00:00 First Steps Developmental Services Expands Services in Woburn https://ml.globenewswire.com/media/ZjcwZDJhNDEtZjQ3Yi00MTFiLTg0MjYtOGUyZWRkZmE5NmY4LTEzMjI2NDctMjAyNi0wNC0xNy1lbg==/tiny/First-Steps-Developmental-Serv.png https://healthheraldgrenada.com/article/906308766-lexicon-to-present-data-at-the-american-academy-of-neurology-aan-annual-meeting Health Herald Grenada en PressRelease 2026-04-17T12:00:00+00:00 Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://healthheraldgrenada.com/article/906309333-cogent-biosciences-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2026 Health Herald Grenada en PressRelease 2026-04-17T12:00:00+00:00 Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://healthheraldgrenada.com/article/906310108-lyra-therapeutics-inc-announces-intention-to-voluntarily-file-form-25-for-delisting-from-nasdaq-and-subsequent-deregistration-with-the-sec Health Herald Grenada en PressRelease 2026-04-17T12:00:00+00:00 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC https://ml.globenewswire.com/media/0ad06b18-5b96-4274-8aa8-c57f0a1a8a87/small/lyra-logo-rgb-small-jpg.jpg https://healthheraldgrenada.com/article/906310195-medicus-pharma-submits-orphan-drug-designation-application-to-u-s-fda-for-skinject-in-gorlin-syndrome Health Herald Grenada en PressRelease 2026-04-17T11:30:00+00:00 Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://healthheraldgrenada.com/article/906310505-alterity-therapeutics-appoints-highly-experienced-biotech-executive-ann-cunningham-to-its-board-of-directors Health Herald Grenada en PressRelease 2026-04-17T11:25:00+00:00 Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://healthheraldgrenada.com/article/906282258-bioxcel-therapeutics-announces-virtual-event-to-discuss-commercial-launch-plan-based-on-market-opportunity-assessment-for-igalmi-in-the-at-home Health Herald Grenada en PressRelease 2026-04-17T11:00:00+00:00 BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting https://ml.globenewswire.com/media/63fea215-2cfc-4e2b-b169-43dcfff60b34/small/btai-logo-png-220x123-png.png https://healthheraldgrenada.com/article/906283356-upstream-bio-to-present-new-data-from-phase-2-vibrant-trial-of-verekitug-at-the-ats-2026-international-conference Health Herald Grenada en PressRelease 2026-04-17T11:00:00+00:00 Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference https://ml.globenewswire.com/media/f1393297-d0b6-4706-960f-6128bcd0c6a4/small/upstream-logo-rgb-300x300px-jpg.jpg https://healthheraldgrenada.com/article/906281138-yaqrit-phase-2a-data-clinical-consensus-boost-yaq007-and-yaq006-in-hepatic-encephalopathy Health Herald Grenada en PressRelease 2026-04-17T10:59:53+00:00 Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy https://ml-eu.globenewswire.com/media/4e2e67d1-3239-456f-b007-beba28c06f71/small/logo-yaqrit-new-jpg.jpg https://healthheraldgrenada.com/article/906283909-invest-in-the-future-of-clean-energy-drinks-us-capital-global-securities-announces-10-million-offering-for-g-o-a-t-fuel Health Herald Grenada en PressRelease 2026-04-17T10:43:41+00:00 Invest in the Future of Clean Energy Drinks: US Capital Global Securities Announces $10 Million Offering for G.O.A.T. Fuel https://ml.globenewswire.com/media/ZDBkNzJlNTUtOGY1ZS00NTRhLWE4NjktYTdjMGM1ODIzZDUyLTExOTk2ODktMjAyNi0wNC0xNy1lbg==/tiny/US-Capital-Global.png https://healthheraldgrenada.com/article/906282624-kura-oncology-reports-darlifarnib-plus-cabozantinib-demonstrates-robust-activity-in-patients-with-clear-cell-renal-cell-carcinoma-previously-treated Health Herald Grenada en PressRelease 2026-04-17T10:00:00+00:00 Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://healthheraldgrenada.com/article/906282818-immuron-double-digit-3q-sales-growth Health Herald Grenada en PressRelease 2026-04-17T10:00:00+00:00 Immuron Double Digit 3Q Sales Growth https://ml.globenewswire.com/media/91da4c25-bccc-44c5-bc67-81258bbb1ba5/medium/global-year-to-date-net-sales-aud.jpg https://healthheraldgrenada.com/article/906260754-new-nordic-white-paper-reveals-systemic-barriers-preventing-women-from-reaching-leadership-roles Health Herald Grenada en PressRelease 2026-04-17T08:00:00+00:00 New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles https://ml-eu.globenewswire.com/media/67f65e0c-87c4-4f95-92fa-0b52d6248335/medium/women-in-life-science-denmark-white-paper.jpg https://healthheraldgrenada.com/article/906260746-bioxodes-expands-clinical-advisory-board-shares-pivotal-trial-design-for-biox-101-in-intracerebral-hemorrhage Health Herald Grenada en PressRelease 2026-04-17T06:30:00+00:00 Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage https://ml-eu.globenewswire.com/media/11568637-8587-499f-8472-d6009ae7d0ba/small/bioxodes-logo-fond-transparent-png.png https://healthheraldgrenada.com/article/906240649-carbios-announces-fiscal-year-2025-financial-results Health Herald Grenada en PressRelease 2026-04-17T05:45:00+00:00 Carbios announces fiscal-year 2025 financial results https://ml-eu.globenewswire.com/media/Mjk4MTcyMDgtZDQ2MS00ZGVkLTk4YjMtNDk2YjFjNTgyN2Y1LTEyMTU1MTctMjAyNi0wNC0xNy1lbg==/tiny/Carbios.png https://healthheraldgrenada.com/article/906240675-carbios-pr-sente-ses-r-sultats-annuels-2025 Health Herald Grenada en PressRelease 2026-04-17T05:45:00+00:00 CARBIOS présente ses résultats annuels 2025 https://ml-eu.globenewswire.com/media/Mjk4MTcyMDgtZDQ2MS00ZGVkLTk4YjMtNDk2YjFjNTgyN2Y1LTEyMTU1MTctMjAyNi0wNC0xNy1mcg==/tiny/Carbios.png https://healthheraldgrenada.com/article/906218955-trevi-therapeutics-announces-pricing-of-150-million-underwritten-offering-of-common-stock Health Herald Grenada en PressRelease 2026-04-17T02:42:00+00:00 Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://healthheraldgrenada.com/article/906198950-orasure-technologies-appoints-john-d-bertrand-to-its-board-of-directors Health Herald Grenada en PressRelease 2026-04-17T00:10:00+00:00 OraSure Technologies Appoints John D. Bertrand to its Board of Directors https://ml.globenewswire.com/media/713ef28e-6d0b-4156-a92f-397061b474cf/small/oti-wordmark-png.png https://healthheraldgrenada.com/article/906198900-kailera-therapeutics-announces-pricing-of-initial-public-offering Health Herald Grenada en PressRelease 2026-04-16T23:25:37+00:00 Kailera Therapeutics Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://healthheraldgrenada.com/article/906198660-picard-medical-syncardia-to-present-next-generation-total-artificial-heart-platform-at-ishlt-2026-in-toronto Health Herald Grenada en PressRelease 2026-04-16T22:56:25+00:00 Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://healthheraldgrenada.com/article/906198752-extendicare-announces-voting-results-for-its-2026-annual-meeting-of-shareholders Health Herald Grenada en PressRelease 2026-04-16T22:55:42+00:00 Extendicare Announces Voting Results for its 2026 Annual Meeting of Shareholders https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://healthheraldgrenada.com/article/906198499-jatt-ii-acquisition-corp-announces-pricing-of-60-000-000-initial-public-offering Health Herald Grenada en PressRelease 2026-04-16T22:30:00+00:00 JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering https://ml.globenewswire.com/media/bdc8f213-b6bf-408e-bb10-139f74e91c08/small/jatt-ii-logo-png.png https://healthheraldgrenada.com/article/906182268-osteoshield-claims-evaluated-premium-quality-bone-density-support-formula-by-peak-health-research Health Herald Grenada en PressRelease 2026-04-16T21:54:52+00:00 OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research https://zingfast.com/wp-content/uploads/2026/04/OsteoShield.jpg https://healthheraldgrenada.com/article/906181735-sanuwave-health-reports-preliminary-q1-2026-revenue-of-9-6-9-7-million-up-3-4-year-over-year Health Herald Grenada en PressRelease 2026-04-16T21:00:00+00:00 Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year https://ml.globenewswire.com/media/6e709528-90af-4ff5-a08a-c0ea5a2cd4ab/small/sanuwave-logo-002-png.png https://healthheraldgrenada.com/article/906181663-zorronet-delivers-98-success-in-israel-railways-pilot-awarded-framework-supply-agreement-for-ai-powered-detection-systems Health Herald Grenada en PressRelease 2026-04-16T20:30:28+00:00 Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems https://ml.globenewswire.com/media/YTY5NmM2ZTgtNDhjNi00NGZmLTg3OTEtNGI5MmI3OTBiYjY2LTEzMjE4NzEtMjAyNi0wNC0xNi1lbg==/tiny/BiomX.png https://healthheraldgrenada.com/article/906180219-globus-medical-schedules-first-quarter-earnings-release-and-conference-call Health Herald Grenada en PressRelease 2026-04-16T20:30:00+00:00 Globus Medical Schedules First Quarter Earnings Release and Conference Call https://ml.globenewswire.com/media/46f81a86-b794-42b0-bf72-63447eb13f53/small/gmlogo-2024-rgb-high-png.png https://healthheraldgrenada.com/article/906181600-vapofil-under-investigation-evaluating-the-vapor-rub-male-enhancement-honey-trick-claims Health Herald Grenada en PressRelease 2026-04-16T20:24:47+00:00 VapoFil Under Investigation: Evaluating the Vapor Rub Male Enhancement Honey Trick Claims https://zingfast.com/wp-content/uploads/2026/04/VapoFil-Reviews.jpg https://healthheraldgrenada.com/article/906181421-spyre-therapeutics-inc-announces-closing-of-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-for-gross Health Herald Grenada en PressRelease 2026-04-16T20:15:00+00:00 Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://healthheraldgrenada.com/article/906180850-lifestance-to-host-first-quarter-2026-earnings-conference-call-on-may-7-2026 Health Herald Grenada en PressRelease 2026-04-16T20:10:00+00:00 LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026 https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://healthheraldgrenada.com/article/906181413-trevi-therapeutics-announces-proposed-public-offering-of-common-stock Health Herald Grenada en PressRelease 2026-04-16T20:08:00+00:00 Trevi Therapeutics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://healthheraldgrenada.com/article/906180185-pacbio-to-report-first-quarter-2026-financial-results-on-may-7-2026 Health Herald Grenada en PressRelease 2026-04-16T20:05:00+00:00 PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://healthheraldgrenada.com/article/906180756-orthopediatrics-corp-to-report-first-quarter-financial-results-on-april-30-2026 Health Herald Grenada en PressRelease 2026-04-16T20:05:00+00:00 OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026 https://ml.globenewswire.com/media/b05026f8-f835-4f46-a103-232db9c6c025/small/ortho-jpg.jpg https://healthheraldgrenada.com/article/906181098-emergent-biosolutions-successfully-refinances-term-loan-amends-asset-backed-loan-facility-and-increases-financial-flexibility Health Herald Grenada en PressRelease 2026-04-16T20:05:00+00:00 Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://healthheraldgrenada.com/article/906181341-emergent-biosolutions-to-report-first-quarter-2026-financial-results-on-april-30-2026 Health Herald Grenada en PressRelease 2026-04-16T20:05:00+00:00 Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026 https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://healthheraldgrenada.com/article/906180879-eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Herald Grenada en PressRelease 2026-04-16T20:01:00+00:00 EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://healthheraldgrenada.com/article/906180932-allogene-therapeutics-announces-closing-of-200-4-million-public-offering-of-common-stock Health Herald Grenada en PressRelease 2026-04-16T20:01:00+00:00 Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://healthheraldgrenada.com/article/906180905-terrascend-appoints-eric-jackson-as-chief-financial-officer Health Herald Grenada en PressRelease 2026-04-16T20:00:00+00:00 TerrAscend Appoints Eric Jackson as Chief Financial Officer https://ml.globenewswire.com/media/3057ae6c-0bfe-49e0-90d4-66688bd859c8/small/picture1-png.png https://healthheraldgrenada.com/article/906159985-new-preclinical-data-on-stx-1-a-first-in-class-senolytic-adc-to-be-presented-at-aacr-2026 Health Herald Grenada en PressRelease 2026-04-16T19:00:00+00:00 New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026 https://ml-eu.globenewswire.com/media/759246b4-e94a-4390-9310-5992d066d0fd/small/starkage-2-1-png.png https://healthheraldgrenada.com/article/906161358-un-nouveau-partenariat-pour-acc-l-rer-la-recherche-innovante-dans-le-domaine-r-nal Health Herald Grenada en PressRelease 2026-04-16T18:52:58+00:00 Un nouveau partenariat pour accélérer la recherche innovante dans le domaine rénal https://ml.globenewswire.com/media/YWQxMzkxODUtMGVmMC00MjViLWE0YzktNzYzMjU4ZTg0Nzc2LTUwMDE1OTA4My0yMDI2LTA0LTE2LWZy/tiny/The-Kidney-Foundation-of-Canad.png https://healthheraldgrenada.com/article/906161336-new-partnership-to-accelerate-innovation-in-kidney-research Health Herald Grenada en PressRelease 2026-04-16T18:52:30+00:00 New Partnership to Accelerate Innovation in Kidney Research https://ml.globenewswire.com/media/72e7ad16-e1ed-44e9-a825-2f85325df0db/small/kf-logo-en-horz-jpg.jpg https://healthheraldgrenada.com/article/906159925-survey-of-correctional-facility-staff-monthly-opioid-treatment-shot-may-help-reduce-medication-misuse Health Herald Grenada en PressRelease 2026-04-16T18:30:00+00:00 Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://healthheraldgrenada.com/article/906160482-new-national-platform-launches-to-bridge-the-gap-in-bereavement-care-introducing-griefsupportdirectory-com Health Herald Grenada en PressRelease 2026-04-16T18:00:00+00:00 New National Platform Launches to Bridge the Gap in Bereavement Care: Introducing GriefSupportDirectory.com https://pressranger.s3.us-west-1.amazonaws.com/3231614/GriefSupportDirectoryLOGO1200x1200.jpg https://healthheraldgrenada.com/article/906159879-ab-science-provides-an-update-on-its-clinical-development-program Health Herald Grenada en PressRelease 2026-04-16T17:20:13+00:00 AB Science provides an update on its clinical development program. https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/logo-jpg.jpg https://healthheraldgrenada.com/article/906159919-ab-science-fait-le-point-sur-son-programme-de-d-veloppement-clinique Health Herald Grenada en PressRelease 2026-04-16T17:20:13+00:00 AB Science fait le point sur son programme de développement clinique https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/ https://healthheraldgrenada.com/article/906160602-protoflow-claims-evaluated-the-high-potency-prostate-support-ingredients-for-day-night-relief Health Herald Grenada en PressRelease 2026-04-16T17:19:59+00:00 ProtoFlow Claims Evaluated: The High Potency Prostate Support Ingredients for Day & Night Relief https://zingfast.com/wp-content/uploads/2026/04/ProtoFlow.jpg https://healthheraldgrenada.com/article/906144199-somnee-smart-sleep-headband-claims-evaluated-does-it-work-wearable-tech-for-restorative-rest-support Health Herald Grenada en PressRelease 2026-04-16T17:16:16+00:00 Somnee Smart Sleep Headband Claims Evaluated: Does It Work? Wearable Tech for Restorative Rest Support https://zingfast.com/wp-content/uploads/2026/04/Somnee-Smart-Sleep-Headband.jpg https://healthheraldgrenada.com/article/906143976-wake-radiology-steps-up-to-the-plate-for-susan-g-komen-triangle-race-for-the-cure Health Herald Grenada en PressRelease 2026-04-16T17:12:38+00:00 Wake Radiology "Steps Up to the Plate" for Susan G. Komen Triangle Race for the Cure https://ml.globenewswire.com/media/b40944d2-76ce-4a2f-8f95-3517f45fb57b/small/wr-logo-2024-png.png https://healthheraldgrenada.com/article/906144157-air-europa-enhances-safety-on-board-by-incorporating-specialized-medical-assistance-during-flights Health Herald Grenada en PressRelease 2026-04-16T17:08:25+00:00 Air Europa Enhances Safety on Board by Incorporating Specialized Medical Assistance During Flights https://ml.globenewswire.com/media/ZjM3OTE4Y2MtZDViMy00ZTNiLTk3ZDYtNGExMDFmZGViYzExLTEyMzYwOTUtMjAyNi0wNC0xNi1lbg==/tiny/MedAire.png https://healthheraldgrenada.com/article/906139405-evaxion-concludes-annual-general-meeting Health Herald Grenada en PressRelease 2026-04-16T15:30:00+00:00 Evaxion concludes Annual General Meeting https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://healthheraldgrenada.com/article/906142443-diverge-health-adds-oakland-southfield-physicians-in-michigan-to-list-of-physician-organization-partners Health Herald Grenada en PressRelease 2026-04-16T15:18:50+00:00 Diverge Health adds Oakland Southfield Physicians in Michigan to List of Physician Organization Partners https://ml.globenewswire.com/media/1022b2c7-9fa0-4c07-b961-01fe372e9f57/small/simple-fc-4x-png.png https://healthheraldgrenada.com/article/906141067-the-infrastructure-play-hiding-in-plain-sight-across-cardiac-care Health Herald Grenada en PressRelease 2026-04-16T15:00:00+00:00 The Infrastructure Play Hiding in Plain Sight Across Cardiac Care https://ml.globenewswire.com/media/fa80d6c4-97b0-465a-b7f0-f79df6f8bc19/small/screenshot-2025-12-09-at-4-53-16-am-1-png.png https://healthheraldgrenada.com/article/906141456-baylor-genetics-to-showcase-the-impact-of-early-genome-sequencing-at-annual-plugs-summit Health Herald Grenada en PressRelease 2026-04-16T15:00:00+00:00 Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit https://ml.globenewswire.com/media/598c9f7b-cb07-4177-8fb3-646230113338/small/baylor-genetics-logo-oct-2025-for-wire-jpg.jpg https://healthheraldgrenada.com/article/906119748-purisaki-berberine-patches-2026-effective-weight-loss-for-women-lose-12-lbs-per-month-read-benefits-ingredients-side-effects-lunch-in-usa Health Herald Grenada en PressRelease 2026-04-16T14:33:59+00:00 Purisaki Berberine Patches 2026 | Effective Weight Loss For Women Lose 12+ lbs per Month Read Benefits, Ingredients, Side Effects, Lunch in USA. https://ml-eu.globenewswire.com/Resource/Download/18cfe3d6-e158-41a8-94e9-e4c1461ac91f/purisaki-berberine-patches-side-effects.png https://healthheraldgrenada.com/article/906126405-confidential-care-to-provide-bravemind-virtual-reality-treatment-to-veterans Health Herald Grenada en PressRelease 2026-04-16T14:31:40+00:00 Confidential Care to Provide BraveMind Virtual Reality Treatment to Veterans https://ml.globenewswire.com/media/23de679e-d628-4baa-ad17-b340e439a04a/small/soldierstrong-logo.jpg https://healthheraldgrenada.com/article/906119888-hearing-aids-market-set-to-reach-14-42-billion-by-2030-marketsandmarkets Health Herald Grenada en PressRelease 2026-04-16T14:30:00+00:00 Hearing Aids Market Set to Reach $14.42 Billion by 2030 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://healthheraldgrenada.com/article/906126291-omada-health-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-may-7-2026 Health Herald Grenada en PressRelease 2026-04-16T14:19:06+00:00 Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://healthheraldgrenada.com/article/906124099-nbpure-launches-at-target-marking-major-retail-expansion Health Herald Grenada en PressRelease 2026-04-16T14:11:00+00:00 NBPure Launches at Target, Marking Major Retail Expansion https://ml.globenewswire.com/media/55a96f57-fe05-4240-987f-0b7995245537/small/nbpure.png https://healthheraldgrenada.com/article/906119956-american-urological-association-releases-clinically-localized-prostate-cancer-guideline-amendment Health Herald Grenada en PressRelease 2026-04-16T14:03:00+00:00 American Urological Association Releases Clinically Localized Prostate Cancer Guideline Amendment https://ml.globenewswire.com/media/MTYwN2UwZTAtZGM4Yy00ZjMzLWFmOGUtMzE5ZTM4OWVmNGZhLTEyNzYxOTAtMjAyNi0wNC0xNi1lbg==/tiny/American-Urological-Associatio.png https://healthheraldgrenada.com/article/906125837-disability-insurance-resource-for-medical-residents-launches-after-record-2026-match Health Herald Grenada en PressRelease 2026-04-16T14:00:32+00:00 Disability Insurance Resource for Medical Residents Launches After Record 2026 Match https://ml.globenewswire.com/media/af288d65-9499-4cf3-9d5c-7dec110ca42e/medium/gsi-disability-insurance-eligibility-deadlines-milestones-ri.jpg https://healthheraldgrenada.com/article/906119616-ai-can-now-understand-health-signals-from-15-seconds-of-your-voice-including-type-2-diabetes-fatigue-and-stress Health Herald Grenada en PressRelease 2026-04-16T14:00:00+00:00 AI can now understand health signals from 15 seconds of your voice, including type 2 diabetes, fatigue and stress https://ml-eu.globenewswire.com/media/23b8317d-2d0f-4ae8-9f7d-6102f0046b06/small/sm-logo-sm-blue-4x-png.png https://healthheraldgrenada.com/article/906125794-nephros-expands-strategic-focus-in-greater-new-york-market-with-dedicated-regional-leadership Health Herald Grenada en PressRelease 2026-04-16T13:57:04+00:00 Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership https://ml.globenewswire.com/media/47f2ed6d-a81f-4174-a3eb-0a46a538285e/small/logo-png.png https://healthheraldgrenada.com/article/906119994-mapi-pharma-to-present-efficacy-edss-data-from-glatiramer-acetate-depot-long-acting-injection-studies-in-relapsing-forms-of-multiple-sclerosis-rms Health Herald Grenada en PressRelease 2026-04-16T13:30:00+00:00 Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026 https://ml.globenewswire.com/media/a15e698a-0f26-4d44-bf6a-78b7ae34d25d/small/mapi-pharma-logo-png.png https://healthheraldgrenada.com/article/906124031-inspira-completes-commercial-deployment-of-its-ame-system-at-a-tier-1-u-s-defense-entity Health Herald Grenada en PressRelease 2026-04-16T13:21:00+00:00 Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://healthheraldgrenada.com/article/906121308-maia-biotechnology-activates-first-u-s-site-for-ongoing-international-phase-2-expansion-trial-of-novel-telomere-targeting-treatment-targeting Health Herald Grenada en PressRelease 2026-04-16T13:20:00+00:00 MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer https://ml.globenewswire.com/media/a53747c9-c908-4493-b907-21f72017c02c/small/maia-logo-png-teal-png.png https://healthheraldgrenada.com/article/906120593-myriad-genetics-to-deliver-six-abstracts-including-two-podiums-at-aacr-2026 Health Herald Grenada en PressRelease 2026-04-16T13:15:00+00:00 Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://healthheraldgrenada.com/article/906125626-nurexone-biologic-inc-announces-fourth-quarter-and-full-year-2025-financial-results-and-provides-corporate-update Health Herald Grenada en PressRelease 2026-04-16T13:15:00+00:00 NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/1514c671-cc84-4bcb-82d7-b834fce40882/small/nurexone-logo-rebrand-large-png.png https://healthheraldgrenada.com/article/906125147-progyny-expands-access-to-fertility-and-women-s-health-with-industry-s-first-fully-insured-supplemental-plan Health Herald Grenada en PressRelease 2026-04-16T13:05:40+00:00 Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://healthheraldgrenada.com/article/906119488-philips-receives-fda-510-k-clearance-for-verida-the-world-s-first-ai-powered-detector-based-spectral-ct-advancing-diagnostic-precision-across Health Herald Grenada en PressRelease 2026-04-16T13:00:00+00:00 Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://healthheraldgrenada.com/article/906120654-retailers-nationwide-partner-with-muscular-dystrophy-association-to-send-hundreds-of-young-people-to-life-changing-summer-camp Health Herald Grenada en PressRelease 2026-04-16T13:00:00+00:00 Retailers Nationwide Partner with Muscular Dystrophy Association to Send Hundreds of Young People to Life-Changing Summer Camp https://ml.globenewswire.com/media/MjRkZDQ0MTAtMmFjNy00MTg3LTljZTItODA3ZGE5YzRiYWQwLTEwOTg0NjYtMjAyNi0wNC0xNi1lbg==/tiny/Muscular-Dystrophy-Association.png https://healthheraldgrenada.com/article/906120666-nearly-4-in-10-women-are-missing-vaginal-bacteria-linked-to-fertility Health Herald Grenada en PressRelease 2026-04-16T13:00:00+00:00 Nearly 4 in 10 women are missing vaginal bacteria linked to fertility https://ml.globenewswire.com/media/2937848e-5793-4af9-9eee-96eeeaf1cd51/medium/tiny-health-fertility-concerns-condition-association.png https://healthheraldgrenada.com/article/906120678-aim-immunotech-enters-pivotal-value-inflection-phase-with-planned-phase-3-study-of-ampligen-in-pancreatic-cancer-backed-by-positive-clinical Health Herald Grenada en PressRelease 2026-04-16T13:00:00+00:00 AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://healthheraldgrenada.com/article/906120688-envue-issues-stockholder-letter-provides-corporate-update Health Herald Grenada en PressRelease 2026-04-16T13:00:00+00:00 ENvue Issues Stockholder Letter & Provides Corporate Update https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://healthheraldgrenada.com/article/906121533-femasys-drives-international-growth-with-israeli-market-entry-for-fertility-portfolio Health Herald Grenada en PressRelease 2026-04-16T13:00:00+00:00 Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://healthheraldgrenada.com/article/906122343-fate-therapeutics-announces-data-presentation-of-ft839-next-generation-off-the-shelf-car-t-cell-product-candidate-for-the-broad-treatment-of Health Herald Grenada en PressRelease 2026-04-16T13:00:00+00:00 Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR… https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://healthheraldgrenada.com/article/906125037-achieve-life-sciences-announces-appointment-of-andrew-d-goldberg-md-as-chief-executive-officer-and-to-the-board-of-directors Health Herald Grenada en PressRelease 2026-04-16T12:57:06+00:00 Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://healthheraldgrenada.com/article/906124768-achieve-life-sciences-announces-up-to-354-million-private-placement Health Herald Grenada en PressRelease 2026-04-16T12:53:49+00:00 Achieve Life Sciences Announces Up to $354 Million Private Placement https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://healthheraldgrenada.com/article/906121350-palisade-bio-announces-abstract-selected-for-poster-presentation-at-digestive-disease-week-ddw-2026 Health Herald Grenada en PressRelease 2026-04-16T12:50:00+00:00 Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026 https://ml.globenewswire.com/media/0beaede8-1c7c-4f77-84a7-b1efd54c343c/small/logo-png.png https://healthheraldgrenada.com/article/906121174-blood-cancer-patients-and-their-supporters-cycle-across-iceland-to-raise-funds-and-awareness-for-multiple-myeloma-and-the-international-myeloma Health Herald Grenada en PressRelease 2026-04-16T12:45:00+00:00 Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research https://ml.globenewswire.com/media/f70068f9-568b-4858-8283-3c96a2db91d6/small/imf-logo-png.png https://healthheraldgrenada.com/article/906107105-profound-medical-to-release-first-quarter-2026-financial-results-on-may-7-conference-call-to-follow Health Herald Grenada en PressRelease 2026-04-16T12:37:49+00:00 Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow https://ml.globenewswire.com/media/94d9e057-9de3-430c-9a19-b41ff3e06a1e/small/profound-logo-cmyk-copy-jpg.jpg https://healthheraldgrenada.com/article/906102154-nanox-arc-x-digital-advanced-3d-imaging-built-for-access-and-powered-by-innovation-wins-2026-red-dot-award-for-product-design Health Herald Grenada en PressRelease 2026-04-16T12:35:00+00:00 Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design https://ml-eu.globenewswire.com/media/7a1764f8-84e3-4b28-ae23-9add5d57c378/small/nanox-logo-4-png.png https://healthheraldgrenada.com/article/906103685-srx-health-solutions-acquires-shares-of-compass-inc-and-increases-investment-in-opendoor-technologies-inc Health Herald Grenada en PressRelease 2026-04-16T12:30:00+00:00 SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc. https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg https://healthheraldgrenada.com/article/906105170-oncotelic-therapeutics-reports-fy-2025-results-highlighting-249m-net-income-and-jv-pipeline-progress Health Herald Grenada en PressRelease 2026-04-16T12:30:00+00:00 Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://healthheraldgrenada.com/article/906105236-cdt-expands-multi-pathway-value-creation-strategy-across-pharma-ip-and-ai-driven-discovery Health Herald Grenada en PressRelease 2026-04-16T12:30:00+00:00 CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery https://ml.globenewswire.com/media/YWExMmUwYzEtOTJmZS00OGQ5LWE3OTgtZTI3ZTljZWZhMWMwLTEyNzQxMDItMjAyNi0wNC0xNi1lbg==/tiny/CDT-Equity-Inc-.png https://healthheraldgrenada.com/article/906103812-biomerica-announces-medicare-administrative-contractor-confirmation-of-individual-claim-review-for-infoods-ibs-opening-a-scalable-medicare Health Herald Grenada en PressRelease 2026-04-16T12:19:00+00:00 Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://healthheraldgrenada.com/article/906102165-ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026 Health Herald Grenada en PressRelease 2026-04-16T12:01:00+00:00 Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://healthheraldgrenada.com/article/906101366-helsinn-appoints-giacomo-braglia-to-the-board-of-directors Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Helsinn appoints Giacomo Braglia to the Board of Directors https://ml-eu.globenewswire.com/media/5159c168-3b3f-444e-bbee-456218d74062/small/helsinn-logo-h-helsinn-blue-and-grey-1-png.png https://healthheraldgrenada.com/article/906101697-dr-falk-pharma-and-renexxion-announce-late-breaker-oral-presentation-of-global-phase-2b-gastroparesis-results-at-digestive-disease-week-ddw-2026 Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Dr. Falk Pharma and Renexxion Announce Late-Breaker Oral Presentation of Global Phase 2b Gastroparesis Results at Digestive Disease Week (DDW) 2026 https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png https://healthheraldgrenada.com/article/906102052-inmune-bio-inc-announces-new-preclinical-data-at-aacr-2026-demonstrating-inb03-xpro1595-overcomes-resistance-and-reduces-metastases-in Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://healthheraldgrenada.com/article/906102244-pacira-to-report-first-quarter-2026-financial-results-on-thursday-april-30-2026 Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026 https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://healthheraldgrenada.com/article/906102524-wellcome-leap-announces-2-million-prize-in-50-million-quantum-for-bio-challenge-program Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Wellcome Leap Announces $2 Million Prize in $50 Million Quantum for Bio Challenge Program https://ml.globenewswire.com/media/d87a734a-b034-417e-9ad6-0e7fd105fd33/small/leaplogo-blacktext-png.png https://healthheraldgrenada.com/article/906102574-aktis-oncology-appoints-industry-research-and-development-veteran-glenn-gormley-md-phd-to-its-board-of-directors Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://healthheraldgrenada.com/article/906102676-elicio-therapeutics-reports-inducement-grants Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Elicio Therapeutics Reports Inducement Grants https://ml.globenewswire.com/media/d588dddd-266e-4f3e-930a-d4c5ba15fe31/small/logo-jpg.jpg https://healthheraldgrenada.com/article/906103495-mimedx-announces-restructuring-and-cost-reduction-initiative Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 MIMEDX Announces Restructuring and Cost Reduction Initiative https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://healthheraldgrenada.com/article/906103530-vtak-definitive-agreement-to-acquire-100-of-fly-flyte-inc-obtains-shareholder-approval Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://healthheraldgrenada.com/article/906103650-totus-medicines-to-present-first-in-class-covalent-irf5-inhibitor-data-at-aai-immunology2026 Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Totus Medicines to Present First-in-Class Covalent IRF5 Inhibitor Data at AAI IMMUNOLOGY2026 https://ml.globenewswire.com/media/3eba21cf-0a86-45b2-a9f6-405a8ffbe407/small/totus-modularlogo-orange-01-50-jpg.jpg https://healthheraldgrenada.com/article/906104085-prime-medicine-appoints-svetlana-makhni-as-chief-financial-officer Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer https://ml.globenewswire.com/media/ebddcf3b-2b71-4df6-99e8-d07617d9e327/small/prime-medicine-logo-approved-color-png.png https://healthheraldgrenada.com/article/906105493-medera-receives-fda-fast-track-designation-for-gene-therapy-targeting-duchenne-muscular-dystrophy-associated-cardiomyopathy Health Herald Grenada en PressRelease 2026-04-16T12:00:00+00:00 Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy https://ml.globenewswire.com/media/914f089c-79de-4cef-91d3-3b50d6e15230/small/medera-simple-horizontal-jpg.jpg https://healthheraldgrenada.com/article/906100725-edap-to-announce-first-quarter-2026-financial-results-on-may-7-2026 Health Herald Grenada en PressRelease 2026-04-16T11:30:00+00:00 EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 https://ml-eu.globenewswire.com/media/ded19329-9645-4860-ac2d-bf3e2422b649/small/focalone-square-logo-drkblue-web-400-1-png.png https://healthheraldgrenada.com/article/906102624-xilio-therapeutics-appoints-cheryl-r-blanchard-ph-d-to-its-board-of-directors Health Herald Grenada en PressRelease 2026-04-16T11:30:00+00:00 Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://healthheraldgrenada.com/article/906103456-paratek-pharmaceuticals-to-present-new-data-on-nuzyra-omadacycline-at-escmid-global-2026 Health Herald Grenada en PressRelease 2026-04-16T11:30:00+00:00 Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026 https://ml.globenewswire.com/media/d492c495-d69c-4507-95f7-5742d0fc1720/small/images-png.png https://healthheraldgrenada.com/article/906103772-korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences Health Herald Grenada en PressRelease 2026-04-16T11:30:00+00:00 Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://healthheraldgrenada.com/article/906104100-helus-pharma-strengthens-medical-leadership-by-appointing-dr-ken-kramer-as-senior-vice-president-medical-affairs Health Herald Grenada en PressRelease 2026-04-16T11:30:00+00:00 Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://healthheraldgrenada.com/article/906103698-kane-biotech-presents-revyve-clinical-data-at-symposium-on-advanced-wound-care-sawc-spring-conference Health Herald Grenada en PressRelease 2026-04-16T11:25:00+00:00 Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference https://ml.globenewswire.com/media/a7606fbc-273a-4100-a03b-cc73a0d8cd61/medium/thermoreversibility-of-us-fda-510k-cleared-revyve-antimicrob.jpg https://healthheraldgrenada.com/article/906104048-alterity-therapeutics-announces-late-breaker-oral-presentation-at-the-american-academy-of-neurology-annual-meeting Health Herald Grenada en PressRelease 2026-04-16T11:25:00+00:00 Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://healthheraldgrenada.com/article/906105594-meiragtx-announces-the-acquisition-of-botaretigene-sparoparvovec-bota-vec-for-the-treatment-of-x-linked-retinitis-pigmentosa-xlrp Health Herald Grenada en PressRelease 2026-04-16T11:10:00+00:00 MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) https://ml.globenewswire.com/media/6b45b8d0-975e-494b-8a46-b88360aa1791/small/mgx-logo-png.png https://healthheraldgrenada.com/article/906100791-beamion-lung-1-study-results-for-zongertinib-in-treatment-na-ve-patients-with-her2-mutant-advanced-nsclc-published-in-the-new-england-journal-of Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://healthheraldgrenada.com/article/906101058-radiopharm-theranostics-completes-enrollment-in-u-s-phase-2b-imaging-trial-of-rad-101-for-diagnosis-of-brain-metastases Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases https://ml-eu.globenewswire.com/media/8e246920-183e-46a4-b13c-a3c9ec50ada9/small/radx-logo-png.png https://healthheraldgrenada.com/article/906102193-marvel-biosciences-identifies-liquid-formulations-for-neurodevelopmental-disorders Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders https://ml.globenewswire.com/media/d49e32dc-88d9-4694-a3dd-6e663548e80d/small/picture1-png.png https://healthheraldgrenada.com/article/906102476-soleo-health-appoints-joy-rowan-as-new-senior-vice-president-of-sales-to-drive-strategic-growth-initiatives Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Soleo Health Appoints Joy Rowan as New Senior Vice President of Sales to Drive Strategic Growth Initiatives https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png https://healthheraldgrenada.com/article/906102687-nula-therapeutics-launches-with-up-to-20-million-arpa-h-award-to-advance-a-new-class-of-medicines-targeting-the-nuclear-envelope-of-cells Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Nula Therapeutics Launches with up to $20 Million ARPA-H Award to Advance a New Class of Medicines Targeting the Nuclear Envelope of Cells https://ml.globenewswire.com/media/23e9dd6f-19b3-4a7d-b756-61a12889b5b6/small/nula-logoexploration-2026-black-png.png https://healthheraldgrenada.com/article/906103383-remedy-plan-therapeutics-announces-multiple-presentations-at-the-aacr-annual-meeting-2026 Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Remedy Plan Therapeutics Announces Multiple Presentations at the AACR Annual Meeting 2026 https://ml.globenewswire.com/media/806541d7-639c-47b8-80fd-3a6fba5ced55/small/full-name-logo-png.png https://healthheraldgrenada.com/article/906103514-metagenomi-therapeutics-inc-announces-publication-in-nature-structural-molecular-biology-highlighting-proprietary-compact-crispr-nuclease-with Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency https://ml.globenewswire.com/media/7680f6bf-0803-4567-93bd-b52fc13a7887/small/new-mgx-logo-png.png https://healthheraldgrenada.com/article/906105297-tiziana-life-sciences-announces-publication-of-positive-data-demonstrating-intranasal-anti-cd3-antibody-attenuates-long-covid-neuroinflammation-and Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function https://ml.globenewswire.com/media/991c340c-a083-4bcb-ad41-e7eea83f6f97/small/tiziana-logo-png.png https://healthheraldgrenada.com/article/906105388-harrow-announces-the-issuance-of-j-code-for-iopidine-1 Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Harrow Announces the Issuance of J-Code for IOPIDINE® 1% https://ml.globenewswire.com/media/8e0382bf-e00a-4591-87aa-4e90001aabea/small/bw-harrow-logo-cmyk-wtag-wr-jpg.jpg https://healthheraldgrenada.com/article/906105490-adlai-nortye-announces-150-0-million-private-placement-equity-financing Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 Adlai Nortye Announces $150.0 Million Private Placement Equity Financing https://ml.globenewswire.com/media/ecf64cce-0b8f-42c4-9a39-9780955f3747/small/adlai-nortye-logo-png.png https://healthheraldgrenada.com/article/906105530-meiragtx-announces-positive-three-year-data-from-the-phase-1-aquax-clinical-study-of-aav-haqp1-for-the-treatment-of-grade-2-3-late-radiation-induced Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia https://ml.globenewswire.com/media/6b45b8d0-975e-494b-8a46-b88360aa1791/small/mgx-logo-png.png https://healthheraldgrenada.com/article/906105606-atum-welcomes-gavin-barnard-ph-d-as-chief-scientific-officer Health Herald Grenada en PressRelease 2026-04-16T11:00:00+00:00 ATUM Welcomes Gavin Barnard, Ph.D., as Chief Scientific Officer https://pressranger.s3.us-west-1.amazonaws.com/3231287/GB-Photo3.jpg https://healthheraldgrenada.com/article/906102791-eton-pharmaceuticals-announces-cfo-succession-plan Health Herald Grenada en PressRelease 2026-04-16T10:50:00+00:00 Eton Pharmaceuticals Announces CFO Succession Plan https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://healthheraldgrenada.com/article/906105588-aclarion-secures-u-s-patent-advancing-scalable-ai-driven-assessment-of-chronic-low-back-pain Health Herald Grenada en PressRelease 2026-04-16T10:47:04+00:00 Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://healthheraldgrenada.com/article/906080545-zymeworks-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-7-2026 Health Herald Grenada en PressRelease 2026-04-16T10:00:00+00:00 Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://healthheraldgrenada.com/article/906081149-aligos-therapeutics-enters-into-exclusive-license-deal-with-xiamen-amoytop-biotech-co-ltd-to-develop-and-commercialize-pevifoscorvir-sodium-in Health Herald Grenada en PressRelease 2026-04-16T10:00:00+00:00 Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://healthheraldgrenada.com/article/906080014-aicuris-receives-fda-priority-review-for-pritelivir-nda-and-presents-new-phase-3-data-at-escmid-2026 Health Herald Grenada en PressRelease 2026-04-16T09:00:00+00:00 Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026 https://ml-eu.globenewswire.com/media/67af2a5c-0ad8-4b2b-96f0-8e7f95f0b69c/small/aicuris-logo-png.png https://healthheraldgrenada.com/article/906059312-alethio-therapeutics-unveils-atx-011-a-breakthrough-mutation-agnostic-antibody-for-treating-essential-thrombocythemia-a-c-2b-market-and Health Herald Grenada en PressRelease 2026-04-16T08:00:00+00:00 Alethio Therapeutics Unveils ATX‑011, a Breakthrough, Mutation‑Agnostic Antibody for Treating Essential Thrombocythemia – a c.$2B Market, and Strengthens Leadership to Accelerate Path to IND https://ml-eu.globenewswire.com/media/feaff9af-2ee5-405f-a373-a186e7295932/medium/steve-r-coats-phd.jpg https://healthheraldgrenada.com/article/906059423-freya-biosciences-announces-positive-phase-1-first-in-human-data-with-fb301-for-ivf-related-embryo-implantation-failure Health Herald Grenada en PressRelease 2026-04-16T07:30:00+00:00 Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure https://ml-eu.globenewswire.com/media/eb134d70-d14e-4ab2-b457-0ccece26cf2f/small/freya-logo-png.png https://healthheraldgrenada.com/article/906059449-storm-therapeutics-secures-56-million-series-c-financing-and-doses-first-patient-in-phase-2-sarcoma-trial-of-stc-15 Health Herald Grenada en PressRelease 2026-04-16T07:00:00+00:00 STORM Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC‑15 https://ml-eu.globenewswire.com/media/1f159389-0c23-4305-b40e-b83e89274cee/small/logo-png.PNG https://healthheraldgrenada.com/article/906059547-atoss-unterst-tzt-charit-bei-der-workforce-management-modernisierung Health Herald Grenada en PressRelease 2026-04-16T07:00:00+00:00 ATOSS unterstützt Charité bei der Workforce Management-Modernisierung https://ml.globenewswire.com/media/24d8ce1e-5bd2-4407-bc66-97e358ca533c/medium/charite-wiebke-peitz.jpg https://healthheraldgrenada.com/article/906059589-cancervax-to-target-colorectal-cancer-following-recent-biodistribution-breakthroughs Health Herald Grenada en PressRelease 2026-04-16T07:00:00+00:00 CancerVax to Target Colorectal Cancer Following Recent Biodistribution Breakthroughs https://ml.globenewswire.com/media/c77c55dd-4af0-4572-8921-b0f75e9f72c2/small/logo-png.png https://healthheraldgrenada.com/article/906040433-greywolf-therapeutics-appoints-edwin-moses-as-chair Health Herald Grenada en PressRelease 2026-04-16T06:00:00+00:00 Greywolf Therapeutics appoints Edwin Moses as Chair https://ml-eu.globenewswire.com/media/969dca71-90d5-4199-ba27-14b8aac5ee6d/medium/dr-edwin-moses-portrait.jpeg https://healthheraldgrenada.com/article/906040834-onward-medical-successfully-raises-over-eur-40-million-in-capital-increase Health Herald Grenada en PressRelease 2026-04-16T05:30:00+00:00 ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://healthheraldgrenada.com/article/906040574-bioversys-announces-first-patient-first-visit-in-habp-vabp-pivotal-phase-3-riv-target-trial-of-bv100 Health Herald Grenada en PressRelease 2026-04-16T05:00:00+00:00 BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100 https://ml.globenewswire.com/media/37dee549-5eb0-418f-a16c-11d8422babfb/small/logo-bioversys-color-rgb-neu-for-prs-jpg.jpg https://healthheraldgrenada.com/article/906001021-uroflow-claims-evaluated-reviewing-the-official-website-benefits-ingredients-to-support-prostate-health Health Herald Grenada en PressRelease 2026-04-16T01:36:43+00:00 UroFlow Claims Evaluated: Reviewing the Official Website Benefits & Ingredients to Support Prostate Health https://zingfast.com/wp-content/uploads/2026/04/UroFlow.jpg https://healthheraldgrenada.com/article/905966552-vivos-therapeutics-reports-full-year-2025-financial-results Health Herald Grenada en PressRelease 2026-04-15T20:20:00+00:00 Vivos Therapeutics Reports Full Year 2025 Financial Results https://ml.globenewswire.com/media/22d07f60-2e17-421d-bbc3-748c2402061e/small/picture2-jpg.JPG https://healthheraldgrenada.com/article/905968198-nexgel-reschedules-shareholder-update-conference-call-to-april-23rd-at-4-30-p-m-et-to-provide-update-on-celularity-transaction Health Herald Grenada en PressRelease 2026-04-15T20:12:00+00:00 NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://healthheraldgrenada.com/article/905967719-teladoc-health-to-announce-first-quarter-2026-financial-results Health Herald Grenada en PressRelease 2026-04-15T20:05:00+00:00 Teladoc Health to Announce First Quarter 2026 Financial Results https://ml.globenewswire.com/media/439ced23-c1ca-477b-8607-8067a1777d11/small/tdh-logo-png.png https://healthheraldgrenada.com/article/905967914-adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026 Health Herald Grenada en PressRelease 2026-04-15T20:05:00+00:00 Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg https://healthheraldgrenada.com/article/905966301-nkarta-announces-fda-agreement-on-outpatient-dosing-of-nkx019-in-autoimmune-disease-expanding-access-to-community-rheumatology-centers Health Herald Grenada en PressRelease 2026-04-15T20:01:00+00:00 Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers https://ml.globenewswire.com/media/09e7df7f-9555-45c9-bef1-86131c859ed3/small/nkarta-logo-2022-jpg.jpg https://healthheraldgrenada.com/article/905966438-anika-to-issue-first-quarter-2026-financial-results-on-wednesday-april-29-2026 Health Herald Grenada en PressRelease 2026-04-15T20:01:00+00:00 Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 https://ml.globenewswire.com/media/342e50d9-f0e4-4e79-b568-840299c2045d/small/anika-new-logo-blue-1200x628-png.png https://healthheraldgrenada.com/article/905966946-wave-life-sciences-announces-proposed-redomiciliation-to-the-united-states Health Herald Grenada en PressRelease 2026-04-15T20:01:00+00:00 Wave Life Sciences Announces Proposed Redomiciliation to the United States https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://healthheraldgrenada.com/article/905967222-traws-pharma-reports-full-year-2025-results-and-provides-business-highlights Health Herald Grenada en PressRelease 2026-04-15T20:01:00+00:00 Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights https://ml.globenewswire.com/media/1eb1780a-724e-4555-ab4d-455e27d18544/small/traws-pharma-blue-png.png https://healthheraldgrenada.com/article/905967681-algernon-health-announces-effective-date-of-previously-announced-name-change-to-grey-matters-health-inc-and-its-10-1-share-consolidation Health Herald Grenada en PressRelease 2026-04-15T20:01:00+00:00 Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation https://ml.globenewswire.com/media/57ab3e9f-6614-45fb-863e-eb22d71c3d2a/small/picture1-jpg.jpg https://healthheraldgrenada.com/article/905966572-elion-therapeutics-announces-initiation-of-turletricin-el219-phase-2-study-in-invasive-mould-infection Health Herald Grenada en PressRelease 2026-04-15T20:00:00+00:00 Elion Therapeutics Announces Initiation of Turletricin (EL219) Phase 2 Study in Invasive Mould Infection https://ml.globenewswire.com/media/4645f248-48c0-4a58-a2bd-f62e313e2b31/small/eliontx-logo-color-rgb-2-jpg.jpg https://healthheraldgrenada.com/article/905967917-arcutis-to-report-first-quarter-2026-financial-results-and-host-conference-call-on-may-6-2026 Health Herald Grenada en PressRelease 2026-04-15T20:00:00+00:00 Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026 https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://healthheraldgrenada.com/article/905949618-the-association-for-frontotemporal-degeneration-aftd-hosts-first-capitol-hill-briefing-frontotemporal-degeneration-shining-a-light-on-a Health Herald Grenada en PressRelease 2026-04-15T19:20:27+00:00 The Association for Frontotemporal Degeneration (AFTD) Hosts First Capitol Hill Briefing: “Frontotemporal Degeneration: Shining a Light on a Little-Known Dementia” https://ml.globenewswire.com/media/OWJjOGJmOTctMmJmOC00NzExLTk5MTUtMmQ5N2EwNzBhZjk3LTEyNzYyMTctMjAyNi0wNC0xNS1lbg==/tiny/Association-for-Frontotemporal.png https://healthheraldgrenada.com/article/905949656-svetlana-mojsov-one-of-the-scientists-behind-ozempic-and-mathematician-carlos-kenig-who-decoded-laws-of-motion-honored-as-king-faisal-prize-2026 Health Herald Grenada en PressRelease 2026-04-15T19:19:26+00:00 Svetlana Mojsov, one of the Scientists behind Ozempic, and Mathematician Carlos Kenig, who Decoded Laws of Motion, Honored as King Faisal Prize 2026 Laureates https://ml.globenewswire.com/media/NTZiODI3YmYtZjVkZC00NTIyLTgzMmYtMTNiYTkzYTMxMTM4LTEyNTgxNjctMjAyNi0wNC0xNS1lbg==/tiny/King-Faisal-Prize.png https://healthheraldgrenada.com/article/905949203-shingles-raises-heart-and-stroke-risk-protect-yourself-with-vaccination Health Herald Grenada en PressRelease 2026-04-15T18:57:20+00:00 Shingles Raises Heart and Stroke Risk: Protect Yourself with Vaccination https://ml.globenewswire.com/Resource/Download/a116ab29-9104-48c4-bca2-d4435afdd0b3/17872-1.jpg https://healthheraldgrenada.com/article/905948978-running-with-purpose-nashville-podiatrist-dr-lanier-shares-expert-tips-for-injury-free-half-marathon-training Health Herald Grenada en PressRelease 2026-04-15T18:45:36+00:00 Running with Purpose: Nashville Podiatrist Dr. Lanier Shares Expert Tips for Injury-Free Half Marathon Training https://ml.globenewswire.com/media/55db2f5c-a3dc-4282-9eba-d32817e25477/medium/family-fitness-in-action.jpeg https://healthheraldgrenada.com/article/905947083-neutrolis-appoints-caren-deardorf-as-chief-business-strategy-officer Health Herald Grenada en PressRelease 2026-04-15T18:00:00+00:00 Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer https://ml.globenewswire.com/media/44cdba09-fdb9-4ee1-b7bf-1dcfe5784800/small/20180228-opr-or-logos-biz-wd-neutrolis-logo-1-jpg.jpg https://healthheraldgrenada.com/article/905933479-assureckd-appoints-former-lumiradx-technical-director-dr-aman-khan-as-chief-technology-officer-to-lead-diagnostic-platform-development Health Herald Grenada en PressRelease 2026-04-15T17:11:20+00:00 AssureCKD Appoints Former LumiraDx Technical Director Dr. Aman Khan as Chief Technology Officer to Lead Diagnostic Platform Development https://ml.globenewswire.com/media/MTI4MWJkOWEtNjkzNy00ZTYzLWI4OWMtZGZmNmRiMDA1N2ZiLTEzMjI2NjUtMjAyNi0wNC0xNS1lbg==/tiny/AssureCKD.png https://healthheraldgrenada.com/article/905930843-basilea-aktion-re-genehmigen-an-der-generalversammlung-2026-alle-antr-ge-des-verwaltungsrats Health Herald Grenada en PressRelease 2026-04-15T16:30:00+00:00 Basilea-Aktionäre genehmigen an der Generalversammlung 2026 alle Anträge des Verwaltungsrats https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://healthheraldgrenada.com/article/905931077-basilea-shareholders-approve-all-proposals-of-the-board-of-directors-at-the-2026-annual-general-meeting Health Herald Grenada en PressRelease 2026-04-15T16:30:00+00:00 Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://healthheraldgrenada.com/article/905933265-onward-medical-launches-capital-increase-for-indicative-amount-of-eur-40-million Health Herald Grenada en PressRelease 2026-04-15T16:19:00+00:00 ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://healthheraldgrenada.com/article/905932908-family-therapist-and-acclaimed-author-to-lead-webinar-on-healthy-co-parenting-boundaries Health Herald Grenada en PressRelease 2026-04-15T16:02:13+00:00 Family Therapist and Acclaimed Author to Lead Webinar on Healthy Co-Parenting Boundaries https://ml.globenewswire.com/media/N2RlYWJmOTktOWI0Mi00Nzg0LWJmM2QtZGRhZjgzM2QzYzMwLTEyNjU4MjMtMjAyNi0wNC0xNS1lbg==/tiny/TalkingParents.png https://healthheraldgrenada.com/article/905916881-inteleos-foundation-medmissions-2026 Health Herald Grenada en PressRelease 2026-04-15T15:33:54+00:00 Inteleos Foundation تعلن عن جائزة MedMissions لعام 2026 لتعزيز نطاق الوصول إلى خدمات التصوير بالموجات فوق الصوتية لصحة الأم في خمس دول https://ml.globenewswire.com/media/ZTdkYjEwNGQtYWUwMS00N2JkLTg5NzctYzg2NTgxOGY1MmQxLTEyNDUwMzItMjAyNi0wNC0xNS1hcg==/tiny/Inteleos-Inc-.png https://healthheraldgrenada.com/article/905916931-inteleos-foundation-annonce-les-laur-ats-du-prix-medmissions-2026-pour-renforcer-l-acc-s-l-chographie-maternelle-dans-cinq-nations Health Herald Grenada en PressRelease 2026-04-15T15:33:54+00:00 Inteleos Foundation annonce les lauréats du Prix MedMissions 2026 pour renforcer l’accès à l’échographie maternelle dans cinq nations https://ml.globenewswire.com/media/ZTdkYjEwNGQtYWUwMS00N2JkLTg5NzctYzg2NTgxOGY1MmQxLTEyNDUwMzItMjAyNi0wNC0xNS1mcg==/tiny/Inteleos-Inc-.png https://healthheraldgrenada.com/article/905913948-what-if-you-could-reboot-sick-cells Health Herald Grenada en PressRelease 2026-04-15T15:00:00+00:00 What if you could reboot sick cells? https://ml-eu.globenewswire.com/media/e93daf2c-fee9-4db8-8c09-bab3a01da23b/medium/targeted-mitochondrial-delivery.jpg